Innovations in the systemic therapy of prostate cancer

被引：0
|
作者：
Dale R. Shepard
Derek Raghavan
机构：
[1] Taussig Cancer Institute,Department of Solid Tumor Oncology
[2] Cleveland Clinic,undefined
来源：
Nature Reviews Clinical Oncology | 2010年 / 7卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Important innovations have been achieved in the development of novel systemic hormonal therapies for the salvage treatment of metastatic castrate-resistant disease. The use of chemotherapy as an adjunct for the treatment of castrate-resistant metastatic disease and local advanced tumors has also resulted in patterns of late toxic effects. The authors review the important advances in the evolution of systemic therapy for the treatment of prostate cancer.
引用
收藏
页码：13 / 21
页数：8
相关论文
共 50 条
  • [1] Innovations in the systemic therapy of prostate cancer
    Shepard, Dale R.
    Raghavan, Derek
    NATURE REVIEWS CLINICAL ONCOLOGY, 2010, 7 (01) : 13 - 21
  • [2] Systemic therapy in metastatic prostate cancer
    Auclerc, G
    ANNALES D UROLOGIE, 2000, 34 (01) : 39 - 48
  • [3] Adjuvant systemic therapy of prostate cancer
    Raghavan, D
    SEMINARS IN ONCOLOGY, 1995, 22 (06) : 633 - 640
  • [4] Management of Prostate Cancer with Systemic Therapy: A Prostate Cancer Unit Perspective
    Campodonico, Fabio
    Ennas, Marco
    Zanardi, Silvia
    Zigoura, Ekaterini
    Piccardo, Arnoldo
    Foppiani, Luca
    Schiavone, Concetta
    Squillace, Lino
    Benelli, Andrea
    De Censi, Andrea
    Grillo-Ruggieri, Filippo
    Introini, Carlo
    CURRENT CANCER DRUG TARGETS, 2021, 21 (02) : 107 - 116
  • [5] Update on systemic therapy for advance prostate cancer
    Carthon, Bradley
    Rossi, Peter J.
    CURRENT PROBLEMS IN CANCER, 2015, 39 (01) : 52 - 62
  • [6] The role of systemic cytotoxic therapy for prostate cancer
    Chang, Sam S.
    Kibel, Adam S.
    BJU INTERNATIONAL, 2009, 103 (01) : 8 - 17
  • [7] The case for systemic therapy alone for prostate cancer
    Sweeney, Christopher
    JOURNAL OF UROLOGY, 2006, 176 (06): : S42 - S46
  • [8] Systemic therapy of prostate cancer in elderly patients
    von Amsberg, Gunhild
    Busenbender, Tobias
    Tilki, Derya
    Bokemeyer, Carsten
    ONKOLOGIE, 2024, 30 (02): : 119 - 128
  • [9] Is there an indication for adjuvant or neoadjuvant systemic therapy in prostate cancer?
    Boergermann, C.
    Miller, K.
    vom Dorp, F.
    Jaeger, T.
    Ruebben, H.
    UROLOGE, 2007, 46 (10): : 1385 - +
  • [10] Therapy - Innovations for cancer
    Mermet, Nathaly
    ACTUALITES PHARMACEUTIQUES, 2008, 47 (471): : 4 - 4
12345